Identification of crucial genes in ventilator associated pneumonia through protein–protein interaction network

REFERENCES

• Hunter JD. Ventilator associated pneumonia. Postgrad Med J. 2006;82:172–178.
   PubMed Web of Science ®Google Scholar
• Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. CHEST Journal. 2002;122:2115–2121.
   PubMed Web of Science ®Google Scholar
• Melsen WG, Rovers MM, Koeman M, Bonten MJ. Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies*. Crit Care Med. 2011;39:2736–2742.
   PubMed Web of Science ®Google Scholar
• Pinner RW, Haley RW, Blumenstein BA, Schaberg DR, Von Allmen SD, Mcgowan JE, Jr. High cost nosocomial infections. Infect Control. 1982:143–149.
   PubMedGoogle Scholar
• Cavalcanti M, Ferrer M, Ferrer R, Morforte R, Garnacho A, Torres A. Risk and prognostic factors of ventilator-associated pneumonia in trauma patients. Crit Care Med. 2006;34:1067–1072.
   PubMed Web of Science ®Google Scholar
• Lillehoj EP, Kim KC. Airway mucus: its components and function. Arch Pharm Res. 2002;25:770–780.
   PubMed Web of Science ®Google Scholar
• Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care. 2005;50:725–741.
   PubMedGoogle Scholar
• Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez F, Barrero-Almodovar A, Garcia-Garmendia J, Bernabeu-Wittell M et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis. 2003;36:1111–1118.
   PubMed Web of Science ®Google Scholar
• Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:196–200.
   PubMed Web of Science ®Google Scholar
• Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infectionsa risk factor for hospital mortality among critically ill patients. CHEST Journal. 1999;115:462–474.
   PubMed Web of Science ®Google Scholar
• Lisboa T, Rello J. Diagnosis of ventilator-associated pneumonia: is there a gold standard and a simple approach? Curr Opin Infect Dis. 2008;21:174–178.
   PubMed Web of Science ®Google Scholar
• Seligman R, Papassotiriou J, Morgenthaler NG, Meisner M, Teixeira P. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care. 2008;12:R11.
   PubMed Web of Science ®Google Scholar
• Klompas M. Does this patient have ventilator-associated pneumonia? JAMA. 2007;297:1583–1593.
   PubMed Web of Science ®Google Scholar
• Textoris J, Loriod B, Benayoun L, Gourraud P-A, Puthier D, Albanèse J et al. An evaluation of the role of gene expression in the prediction and diagnosis of ventilator-associated pneumonia. Anesthesiology. 2011;115:344–352.
   PubMed Web of Science ®Google Scholar
• Arcaroli J, Fessler MB, Abraham E. Genetic polymorphisms and sepsis. Shock. 2005;24:300–312.
   PubMed Web of Science ®Google Scholar
• Swanson JM, Wood GC, Xu L, Tang LE, Meibohm B, Homayouni R et al. Developing a gene expression model for predicting ventilator-associated pneumonia in trauma patients: a pilot study. PloS One. 2012;7:e42065.
   PubMed Web of Science ®Google Scholar
• Croce MA, Fabian TC, Waddle-Smith L, Maxwell RA. Identification of early predictors for post-traumatic pneumonia. Am Surg. 2001;67:105–110.
   PubMed Web of Science ®Google Scholar
• Smyth GK, Speed T. Normalization of cDNA microarray data. Methods. 2003;31:265–273.
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Hobbs B, Collin F, BeazerBarclay YD, Antonellis KJ, Scherf U et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–264.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995:289–300.
   Google Scholar
• Hulsegge I, Kommadath A, Smits MA. Globaltest and GOEAST: two different approaches for Gene Ontology analysis. In BMC proceedings. 2009: BioMed Central Ltd.
   Google Scholar
• Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2011;gkr988.
   Google Scholar
• Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39:D561-D568.
   PubMed Web of Science ®Google Scholar
• Matys V, Fricke E, Geffers R, Gößling E, Haubrock M, Hehl R et al. TRANSFAC®: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003;31:374–378.
   PubMed Web of Science ®Google Scholar
• Yen C-C, Shen C-J, Hsu W-H, Chang Y-H, Lin H-T, Chen H-L et al. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection. Biometals. 2011;24:585–594.
   PubMed Web of Science ®Google Scholar
• Spadaro M, Caorsi C, Ceruti P, Varadhachary A, Forni G, Pericle F et al. Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. FASEB J. 2008;22:2747–2757.
   PubMed Web of Science ®Google Scholar
• Lupetti A, Brouwer CP, Dogterom-Ballering HE, Senesi S, Campa M, Van Dissel JT et al. Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin. J Antimicrob Chemother. 2004;54:603–608.
   PubMed Web of Science ®Google Scholar
• Legrand D, Mazurier J. A critical review of the roles of host lactoferrin in immunity. Biometals. 2010;23:365–376.
   PubMed Web of Science ®Google Scholar
• Sedwick MB, Lance-Smith M, Reeder SJ, Nardi J. Using evidence-based practice to prevent ventilator-associated pneumonia. Crit Care Nurse. 2012;32:41–51.
   PubMedGoogle Scholar
• Labeau S, Blot S. Research priorities in oral care for endotracheally-intubated patients, in Annual Update in Intensive Care and Emergency Medicine 2011. Berlin Heidelberg: Springer; 2011:144–155.
   Google Scholar
• Liu Y, Shepherd EG, Nelin LD. MAPK phosphatases —regulating the immune response. Nat Rev Immunol. 2007;7:202–212.
   PubMed Web of Science ®Google Scholar
• Hale KK, Trollinger D, Rihanek M, Manthey CL. Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages. J Immunol. 1999;162:4246–4252.
   PubMed Web of Science ®Google Scholar
• Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808–811.
   PubMed Web of Science ®Google Scholar
• Perregaux DG, Dean D, Cronan M, Connelly P, Gabel CA. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence. Mol Pharmacol. 1995;48:433–442.
   PubMed Web of Science ®Google Scholar
• Vincent J-L, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin M-H et al. The prevalence of nosocomial infection in intensive care units in Europeresults of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA. 1995;274:639–644.
   PubMed Web of Science ®Google Scholar
• Cox D, Pontes C, Guino E, Navarro M, Osorio A, Canzian F et al. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer. 2004;91:339–343.
   PubMed Web of Science ®Google Scholar
• Sadikot RT, Zeng H, Azim AC, Joo M, Dey SK, Breyer RM et al. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX‐2. Eur J Immunol. 2007;37:1001–1009.
   PubMed Web of Science ®Google Scholar
• Schmeck B, Moog K, Zahlten J, Van Laak V, N'Guessan PD, Opitz B et al. Streptococcus pneumoniae induced c-Jun-N-terminal kinase-and AP-1-dependent IL-8 release by lung epithelial BEAS-2B cells. Respir Res. 2006;7: 7149–7155.
   Web of Science ®Google Scholar
• N'Guessan PD, Schmeck B, Ayim A, Hocke AC, Brell B, Hammerschmidt S et al. Streptococcus pneumoniae R6x induced p38 MAPK and JNK-mediated caspase-dependent apoptosis in human endothelial cells. Thrombosis and Haemostasis-Stuttgart-. 2005;94:295.
   PubMed Web of Science ®Google Scholar
• Koch A, Giembycz M, Ito K, Lim S, Jazrawi E, Barnes PJ et al. Mitogen-activated protein kinase modulation of nuclear factor-κB–induced granulocyte macrophage–colony-stimulating factor release from human alveolar macrophages. Am J Respir Cell Mol Biol. 2004;30:342–349.
   PubMed Web of Science ®Google Scholar
• Karin M, Liu Z-G, Zandi E. AP-1 function and regulation. Current opinion in cell biology. 1997;9:240–246.
   Google Scholar
• Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene. 2001;20:2390–2400.
   PubMed Web of Science ®Google Scholar
• Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270:16483– 16486.
   PubMed Web of Science ®Google Scholar
• Balasubramanian A, Ganju RK, Groopman JE. Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes. J Biol Chem. 2003;278:35755–35766.
   PubMed Web of Science ®Google Scholar
• Cho N-H, Seong S-Y, Choi M-S, Kim I-S. Expression of chemokine genes in human dermal microvascular endothelial cell lines infected with Orientia tsutsugamushi. Infect Immun. 2001;69:1265–1272.
   PubMed Web of Science ®Google Scholar
• Wagner EF, Eferl R. Fos/AP‐1 proteins in bone and the immune system. Immunol Rev. 2005;208:126–140.
   PubMed Web of Science ®Google Scholar
• Huang B, Dong Y, Cheng Y, Xie Q, Lin G, Wu Y et al. Chlamydia pneumoniae infection and hyperlipidaemia-induced expression of P50 and c-Fos in the heart of C57BL6J mice. Acta Cardiol. 2008;63:175–179.
   PubMed Web of Science ®Google Scholar